Lu et al., identified an anti-tumour role for IL-17 in enhancing anti-tumour immunity by promoting the migration of NK cells, T cells and dendritic cells in oesophageal squamous cell carcinoma patients and in enhancing the killing capability of B cells through enhanced expression of Granzyme B and FasL (Lu 2016). Here, IL17A is linked to neoplasm.